Fig. 2.

Characteristics of the sources of evidence. CR case report, CS case series, CC case control, pros prospective cohort study, retro retrospective cohort study, ISTH International Society on Thrombosis and Haemostasis, JAAM Japanese Association for acute medicine, JMHW Japanese Ministry of Health and Welfare, SIC sepsis-induced coagulopathy, P-UFH prophylactic dose of unfractionated heparin, T-UFH therapeutic dose of unfractionated heparin, P-LMWH prophylactic dose of low molecular weight heparin, T-LMWH therapeutic dose of low molecular weight heparin, rTM recombinant thrombomodulin, SE side effects, No. number